Application of surfactin for mycoplasma inactivation in virus stocks.
Nissen
E
E
Pauli
G
G
Vater
J
J
Vollenbroich
D
D
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D001426:Bacterial Proteins / Q000494:pharmacology*; D001431:Bacteriological Techniques; D002417:Cattle; D001908:Diarrhea Viruses, Bovine Viral / Q000502:physiology; D011558:Herpesvirus 1, Suid / Q000502:physiology; D006801:Humans; D055666:Lipopeptides; D004680:Maus Elberfeld virus / Q000502:physiology; D051379:Mice; D009174:Mycoplasma / Q000187:drug effects* / Q000302:isolation & purification; D009227:Myristic Acids / Q000494:pharmacology; D017992:Parvovirus / Q000502:physiology; D010456:Peptides, Cyclic; D014776:Virus Cultivation; D018406:Virus Physiological Phenomena; D014780:Viruses / Q000302:isolation & purification
D000903:Antibiotics, Antineoplastic; D001426:Bacterial Proteins; D055666:Lipopeptides; D009227:Myristic Acids; D010456:Peptides, Cyclic; C009365:surfactin peptide